These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27298447)

  • 1. Degenerative ataxias, from genes to therapies: The 2015 Cotzias Lecture.
    Pulst SM
    Neurology; 2016 Jun; 86(24):2284-90. PubMed ID: 27298447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
    Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
    Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advance in research on spinocerebellar ataxia 2].
    Jing F; Yang D; Chen T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):284-287. PubMed ID: 29653012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
    Scoles DR; Dansithong W; Pflieger LT; Paul S; Gandelman M; Figueroa KP; Rigo F; Bennett CF; Pulst SM
    Hum Mol Genet; 2020 Jun; 29(10):1658-1672. PubMed ID: 32307524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
    Kasumu A; Bezprozvanny I
    Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
    Sen NE; Canet-Pons J; Halbach MV; Arsovic A; Pilatus U; Chae WH; Kaya ZE; Seidel K; Rollmann E; Mittelbronn M; Meierhofer D; De Zeeuw CI; Bosman LWJ; Gispert S; Auburger G
    Neurobiol Dis; 2019 Dec; 132():104559. PubMed ID: 31376479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.
    Szpisjak L; Zadori D; Klivenyi P; Vecsei L
    CNS Neurol Disord Drug Targets; 2019; 18(4):279-293. PubMed ID: 30864514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
    Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
    Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.
    Coarelli G; Brice A; Durr A
    F1000Res; 2018; 7():. PubMed ID: 30473770
    [No Abstract]   [Full Text] [Related]  

  • 11. A comprehensive review of spinocerebellar ataxia type 2 in Cuba.
    Velázquez-Pérez L; Rodríguez-Labrada R; García-Rodríguez JC; Almaguer-Mederos LE; Cruz-Mariño T; Laffita-Mesa JM
    Cerebellum; 2011 Jun; 10(2):184-98. PubMed ID: 21399888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.
    Hansen ST; Meera P; Otis TS; Pulst SM
    Hum Mol Genet; 2013 Jan; 22(2):271-83. PubMed ID: 23087021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
    Egorova PA; Zakharova OA; Vlasova OL; Bezprozvanny IB
    J Neurophysiol; 2016 Jun; 115(6):2840-51. PubMed ID: 26984424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain pathology of spinocerebellar ataxias.
    Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
    Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2.
    Egorova PA; Gavrilova AV; Bezprozvanny IB
    Cell Calcium; 2021 Jan; 93():102319. PubMed ID: 33248384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide therapeutics in neurodegenerative diseases.
    Scoles DR; Pulst SM
    RNA Biol; 2018; 15(6):707-714. PubMed ID: 29560813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
    Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
    Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.
    Brown AS; Meera P; Altindag B; Chopra R; Perkins EM; Paul S; Scoles DR; Tarapore E; Magri J; Huang H; Jackson M; Shakkottai VG; Otis TS; Pulst SM; Atwood SX; Oro AE
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12407-E12416. PubMed ID: 30530649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
    Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
    Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central auditory processing in patients with spinocerebellar ataxia.
    Zeigelboim BS; de Carvalho HA; Teive HA; Liberalesso PB; Jurkiewicz AL; da Silva Abdulmassih EM; Marques JM; Cordeiro ML
    Hear Res; 2015 Sep; 327():235-44. PubMed ID: 26183435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.